Lucrezia F.
- Country
- Italy
- Department
- UOC Chirurgia dei Trapianti Rene e Pancreas
Research Overview
- Frexalimab Versus Tacrolimus for Prevention of Kidney Graft Rejection in Adult Kidney Transplant Recipients
- Phase 2 Study of Empasiprubart in Deceased Donor Renal Allograft Recipients at Risk for Delayed Graft Function
- Efficacy and Safety of Imlifidase in Desensitizing Highly Sensitized End-Stage CKD Patients for Kidney Transplantation with Positive Crossmatch
Data & Insights
Has run more than one trial at 36 of 90 partner sites.
Specializations
Kidney Transplantation
The investigator specializes in advanced kidney transplant procedures, with particular emphasis on managing highly sensitized patients requiring specialized immunological interventions.
- Transplant Immunology
- Antibody-Mediated Rejection Prevention
- Graft Survival Optimization
Notable focus includes innovative approaches to enable successful transplantation in challenging immunological scenarios.
Graft Function Management
Expertise in addressing delayed graft function in deceased donor kidney transplants, exploring novel therapeutic interventions to improve transplant outcomes.
- Post-Transplant Care
- Allograft Function Enhancement
- Deceased Donor Outcomes
Focuses on developing strategies to optimize immediate post-transplant organ function and long-term survival.
End-Stage Renal Disease
Dedicated to treating patients with end-stage chronic kidney disease, particularly those awaiting transplantation with complex immunological profiles.
- Pre-transplant Assessment
- Sensitization Management
- Long-term Follow-up Care
Specializes in comprehensive care pathways for highly sensitized patients from pre-transplant evaluation through post-transplant monitoring.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.